The Efficacy of Palmitoylethanolamide (Levagen+) on the Incidence and Symptoms of Upper Respiratory Tract Infection-A Double Blind, Randomised, Placebo-Controlled Trial.

For participants reporting a URTI, the Levagen+ group reported a significantly lower severity score for scratchy throat and cough, with hoarseness and the ability to breathe easily trending towards significance ( Table 4 ) when compared to the placebo group.

also in 515 other papers